Nutrition Action – Article quotes John Baron, professor of medicine, epidemiology, and community and family medicine emeritus, about a study on fiber and its role in preventing colon cancer.
Archive for 2015
Geography Affects What Medicine Seniors Get
Defiance Crescent News – Quotes Jeffrey Munson, assistant professor of medicine and of the Dartmouth Institute for Health Policy and Clinical Practice, on new research from the Dartmouth Atlas of Health Care which found that where seniors live makes a difference not only to how much health care they receive but also the medications they’re prescribed—as some miss out on key treatments while others get risky ones.
In Tough Diagnostics World, Will Ruling Out Cancer Be Good Business?
Xconomy – Quotes H. Gilbert Welch, professor of medicine, community and family medicine, and of the Dartmouth Institute for Health Policy and Clinical Practice, on new molecular “rule-out” tests, based on genomic or proteomic analysis, that can tell someone who has suspicious lung nodules if they don’t have cancer and route them away from unnecessary procedures. “It’s a great direction to move, and intellectually I can appreciate the effort,” says Welch. “But the question is how well (do they) perform, and how do we decide whether the tests actually work?”
Dartmouth Professors Call Out Drug Companies for “Selling a Disease”
The Legal Examiner – Cites an opinion piece published in The Washington Post by Steven Woloshin and Lisa Schwartz, both professors of medicine, community and family medicine, and of the Dartmouth Institute for Health Policy and Clinical Practice, on testosterone drug risks. In the opinion piece, Woloshin and Schwartz criticized testosterone drug therapy manufacturers for creating “disease-awareness” campaigns that put many men at risk of serious side effects, including heart attack and stroke.
E2F4 Predictive of Progression and Immunotherapy Efficacy in Bladder Cancer
Targeted Oncology – Quotes Chao Cheng, assistant professor of genetics and lead author of a recent study on the biomarker E2F4. The biomarker predicts survival in breast cancer, and Cheng’s research suggests that E2F4 may also predict progression and immunotherapy efficacy in bladder cancer.
Migraine Ups Stroke Risk, but Only in Smokers
Medscape – Quotes Thomas Ward, professor of neurology, on a recent study which shows that migraines are associated with an increased risk for stroke among active smokers, but not nonsmokers. Ward says that the study “does confirm that smoking and migraine is a bad combination, and already known to be even worse if the patient is taking exogenous estrogen.”
Medicare and Medicaid Need to Be Transformed
The New York Times – An opinion piece on why Medicaid and Medicare need to be reformed, which cites research conducted by Dartmouth, Harvard, and MIT, estimating the value of Medicaid. The researchers found that for every dollar of spending, the value to recipients is between 20 cents and 40 cents.
Giving Water to Fitness: Woodsville Man Hopes ‘H.A.T.S.’ Can Be Right Fit
Valley News – Quotes Melanie Lawrence, clinical assistant professor of community and family medicine, on the potential construction of a nonprofit water therapy and swimming center in the Woodsville, N.H. – Wells River, V.T., area. “The therapeutic and medical reasons I think would draw a lot of people,” says Lawrence. “Gravity is much less of a restriction for physical therapy in the water, and that type of modality is really important particularly for elderly people with joint issues.”
AAFP Joins Drive For All Clinical Trials to Register, Report Results
American Academy of Family Physicians – Quotes Steven Woloshin, professor of medicine, community and family medicine, and of the Dartmouth Institute for Health Policy & Clinical Practice on the AllTrials campaign, which is calling for all past and present clinical trials in the United States to be registered and report their results.
Dartmouth Receives NIH Grant to Launch Northeast Node of National Drug Abuse Clinical Trials Network
The National Institute on Drug Abuse (NIDA) has awarded a five-year $3.8 million grant to Dartmouth’s Center for Technology and Behavioral Health. The award will support the launch of the new Northeast Node in NIDA’s National Clinical Trials Network, and clinical trials conducted by the Node will be supported by additional research project grants from NIDA, part of the National Institutes of Health.
